12/2014. Clustoid Study
It has been published in the journal Allergy a clinical trial, randomized double-blind, placebo-controlled study, performed in Germany with CLUSTOID.
Title: “A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol”
Authors: Klimek L, Uhlig J, Mösges R, Rettig K, Pfaar O.
Center for Rhinology and Allergology, Wiesbaden; Germany
Roxall Medizin, Hamburg; Germany
IMSIE, University of Cologne, Cologne; Germany
GEM, Bureau of Evaluation & Quality Assurance in Medicine GmbH, Meerbusch, Germany
CLUSTOID is an allergy vaccine containing glutaraldehyde-polymerized allergens. CLUSTOID is manufactured by INMUNOTEK and marketed in Germany by Roxall Medizin GmbH. In other countries is also marketed as CLUSTOID (Spain, Austria and Italy), or as CLUSTEK/ALXOID.
This is the second paper on the clinical efficacy of CLUSTOID. See the first one